Antimicrobial resistance or decreased susceptibiity (DS/R) to in United States of America
United States of America: Antimicrobial resistance or decreased susceptibiity (DS/R) to was 4.1 in 2022. ◆ Volatile
Latest (2022)
4.1
Change on year
down 29.3%
World rank
34th
of 54 countries
All-time high
5.8
in 2020
All-time low
0.21
in 2009
Years of data
12
2009–2022
Antimicrobial resistance or decreased susceptibiity (DS/R) to in United States of America, 2009–2022
Source: World Health Organization, Global Health Observatory.
Analysis
United States of America recorded 4.1 for antimicrobial resistance or decreased susceptibiity (ds/r) to in 2022.
The figure is down 29.3% on the previous year and up 1,418.5% over ten years.
Over the whole period, antimicrobial resistance or decreased susceptibiity (ds/r) to in United States of America peaked at 5.8 in 2020 and was at its lowest, 0.21, in 2009.
United States of America ranks 34th of 54 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Antimicrobial resistance or decreased susceptibiity (DS/R) to in United States of America, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 0.21 | — |
| 2010 | 0.47 | +123.8% |
| 2011 | 0.29 | -38.3% |
| 2012 | 0.27 | -6.9% |
| 2013 | 0.56 | +107.4% |
| 2014 | 2.43 | +333.9% |
| 2015 | 2.58 | +6.2% |
| 2016 | 3.61 | +39.9% |
| 2017 | 4.37 | +21.1% |
| 2018 | 4.55 | +4.1% |
| 2020 | 5.8 | +27.5% |
| 2022 | 4.1 | -29.3% |
United States of America compared with similar countries
- United States of America's 4.1 is below the median for high income countries, which is 14.54, 28% of the median. (34 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.21 | 0.21 | 0.21 | 1 |
| 2010s | 2.13 | 0.27 | 4.55 | 9 |
| 2020s | 4.95 | 4.1 | 5.8 | 2 |
Countries ranked near United States of America
More health data for United States of America
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.1867 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,069 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4,015 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2023)
- Population ages 00-04, female, annual growth rate 0.056 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0261 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.1919 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antimicrobial resistance or decreased susceptibiity (ds/r) to in United States of America?
- Antimicrobial resistance or decreased susceptibiity (ds/r) to in United States of America was 4.1 in 2022, according to World Health Organization, Global Health Observatory.
- What is the highest antimicrobial resistance or decreased susceptibiity (ds/r) to recorded in United States of America?
- The highest recorded value was 5.8 in 2020.
- What is the lowest antimicrobial resistance or decreased susceptibiity (ds/r) to recorded in United States of America?
- The lowest recorded value was 0.21 in 2009.
- How does United States of America rank for antimicrobial resistance or decreased susceptibiity (ds/r) to?
- United States of America ranks 34th out of 54 countries with data for 2022.
- Is antimicrobial resistance or decreased susceptibiity (ds/r) to rising or falling in United States of America?
- Over the last ten years it is up 1,418.5%. The long-run trend across the full record is volatile.
- Where does this United States of America data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 12 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).